HC Wainwright & Co. Adjusts LifeMD Price Target to $6.00
HC Wainwright & Co. has lowered its price target for LifeMD, Inc. from $9.00 to $6.00 per share.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
HC Wainwright & Co. has lowered its price target for LifeMD, Inc. from $9.00 to $6.00 per share.
Gainers Cerenome (NASDAQ:CNSY) shares rose 39.5% to $1.07 during Friday's regular session. The market value of their outstanding shares is at $5.8 million. As per the press release, Q3 earnings came out today. SBC
LifeMD updated its full-year 2026 revenue outlook, reducing the forecast to a range of $188 million to $191 million.
LifeMD reported its third-quarter 2026 financial results, highlighting a revenue of $44.6 million and an adjusted EBITDA loss of approximately $0.4 million.
The Law Offices of Frank R. Cruz has launched an investigation into potential securities fraud at LifeMD, Inc. following a 14.56% decline in the company's stock price.